We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

13 hedge funds and large institutions have $307K invested in Enveric Biosciences in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0.01% less ownership

Funds ownership: 0.05% → 0.04% (-0.01%)

13% less funds holding

Funds holding: 15 → 13 (-2)

37% less capital invested

Capital invested by funds: $488K → $307K (-$181K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$65.4K
2
UBS Group
UBS Group
Switzerland
+$32.3K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$26.4K
4
TSS
Two Sigma Securities
New York
+$12.8K
5
Osaic Holdings
Osaic Holdings
Arizona
+$301

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$43.6K
2
Citadel Advisors
Citadel Advisors
Florida
-$40.1K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$18.2K
4
VF
Virtu Financial
New York
-$16.7K
5
Two Sigma Investments
Two Sigma Investments
New York
-$15.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$190K +$65.4K +434 +33%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$27.7K +$26.4K +175 +240%
UBS Group
3
UBS Group
Switzerland
$27.3K +$32.3K +214 +764%
BlackRock
4
BlackRock
New York
$18.5K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$11.4K – – –
TSS
6
Two Sigma Securities
New York
$9.54K +$12.8K +85 New
VF
7
Virtu Financial
New York
$9K -$16.7K -111 -59%
TRCT
8
Tower Research Capital (TRC)
New York
$7.17K -$603 -4 -6%
HF
9
HRT Financial
New York
$6K -$43.6K -289 -83%
Osaic Holdings
10
Osaic Holdings
Arizona
$385 +$301 +2 +200%
Group One Trading
11
Group One Trading
Illinois
$169 – – –
Bank of America
12
Bank of America
North Carolina
$103 – – –
Fidelity Investments
13
Fidelity Investments
Massachusetts
$74 +$151 +1 New
National Bank of Canada
14
National Bank of Canada
Quebec, Canada
$41 – – –
Wells Fargo
15
Wells Fargo
California
$10 – – –
MG
16
Mather Group
Illinois
$8 – – –
OP
17
ORG Partners
Indiana
$5 – – –
Citadel Advisors
18
Citadel Advisors
Florida
– -$40.1K -223 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$18.2K -101 Closed
Two Sigma Investments
20
Two Sigma Investments
New York
– -$15.4K -86 Closed
Morgan Stanley
21
Morgan Stanley
New York
– -$1 – –

ENVB Hedge Fund Activity: Q2 2024 in Review

13 of the 6,929 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q2 2024, worth a combined $307K — down 37% from $488K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ENVB and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was AdvisorShares Investments, adding an estimated $65.4K. The largest seller was HRT Financial, cutting an estimated $43.6K.

  • 13 institutional investors held Enveric Biosciences (ENVB) as of Q2 2024, down from 15 in Q1 2024.
  • Funds reported $307K of Enveric Biosciences stock for Q2 2024, down 37% quarter-over-quarter.
  • 2 funds opened new Enveric Biosciences positions in Q2 2024 and 4 closed out, a net change of -2 holders.
  • The largest Enveric Biosciences buyer in Q2 2024 was AdvisorShares Investments, an estimated $65.4K added.
  • The largest Enveric Biosciences seller in Q2 2024 was HRT Financial, an estimated $43.6K sold.

Based on aggregated 13F filings for Q2 2024.